Price movement over the last 24 hours
AbCellera Biologics Inc vs VanEck Video Gaming and eSports ETF — how do they compare? AbCellera Biologics Inc trades at $7.17 (market cap $2.35B), while VanEck Video Gaming and eSports ETF trades at $92.17. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | ESPO | |
|---|---|---|
Market Cap | $2.35B | — |
Sector | Health | Sector/Thematic |
52-Week High | $8.12 | $122.30 |
52-Week Low | $2.78 | $85.25 |
Enterprise Value | $1.99B | — |
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
ESPO (VanEck Video Gaming and eSports ETF) trades at $92.89, up 1.04% with bullish technical signals from moving averages. The ETF benefits from AI-driven gaming industry growth potential, with institutional interest shown by Assetmark's 35.9% position increase. Technical indicators show strong trend momentum despite overbought short-term RSI conditions.
The gaming ETF presents exposure to digital entertainment's structural growth, with AI potentially unlocking $22B in industry profits. Key risks include thematic ETF volatility and gaming sector competition. Support at $91-$92 levels provides near-term technical foundation for the current bullish trend.
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →